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Significant outcomes 
 Deficits in the depressed group were particularly prominent in the domains of 
attention and executive function. 
 The attentional deficit persisted statistical control of variability in executive 
function whilst the executive deficit did not survive statistical control of 
variability in attention, indicating that the executive deficit may be secondary to 
the attentional deficit in major depressive disorder.  
 Attention was negatively associated with illness duration. 
Limitations 
 A data driven approach for composite construction was not possible due to the 
small sample size, which meant that the findings rest on the theoretical 
assumption that the included measures tap the intended cognitive domains. 
 Data was not available for all participants for all cognitive measures. 
 The statistical methods used did not allow for causal inferences to be made. 
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Abstract 
Objective: Cognitive dysfunction is an established feature of major depressive disorder 
(MDD). However, it remains unclear whether deficits in different cognitive domains are 
relatively independent or originate from a circumscribed ‘primary deficit’. The present 
study tested the hypothesis that a deficit in attention represents a primary deficit in 
depression.    
Method: Neuropsychological function was assessed in 30 depressed MDD patients and 
34 control participants. Cognitive composites were derived from a minimum of three 
tests and included attention, executive function, visuospatial memory and verbal memory. 
A multivariate analysis of variance was used to assess group differences in overall 
cognitive performance and multiple regression models were used to evaluate the role of 
attention in deficits in other domains. 
Results: The cognitive deficit in the depressed sample was found to be characterized by 
poorer performance in attention and executive function. When evaluating the 
interrelationship between the two deficits, the attentional deficit was found to persist 
when variability in executive function was statistically accounted for whilst the executive 
deficit was eliminated when attention was accounted for. 
Conclusion: The results demonstrated that the attentional deficit could not be explained 
by deficits in executive function, which provides support for a primary attention deficit in 
depression.  
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Background 
Cognitive deficits1 constitute a well-established feature of major depressive disorder 
(MDD; (1)). Encapsulated in the Statistical Manual of Mental Disorders (5th ed.; DSM–
V) as a “diminished ability to think or concentrate, or indecisiveness” (2), they have been 
empirically demonstrated throughout the course of the illness, from the first episode into 
remission (3, 4). Their clinical importance has been supported by associations with 
greater disability in life and work functioning as well as an increased risk of relapse (5, 
6). Cognitive deficits in MDD have been found to affect several domains, including 
executive function, processing speed, attention and memory (7-9).  
Whilst cognitive deficits represent an established feature of MDD, the relative impact of 
and interrelationships amongst deficits in different cognitive domains remains poorly 
understood (10-13). To merely describe the cognitive deficit profile in depression as 
‘broad’ would fail to acknowledge both the hierarchical organisation of human cognitive 
processes and the complex interplay between these processes. Crucially, the 
conceptualisation of any observed deficit profile is fundamentally altered if the processes 
assessed do not operate independently but are instead secondary to reductions in more 
circumscribed, core functions. As such, deficits in different domains may represent 
relatively independent processes with distinct neurobiological underpinnings or may be 
secondary to a primary cognitive deficit in a single domain (14, 15).  
The interrelationships amongst deficits in different cognitive domains have been studied 
most extensively in depressed patients over the age of 60 (late-life depression; (16)). In 
this group, executive function and processing speed have been identified as the most 
pronounced of the deficits (17, 18) with contributions to deficits in other domains, such 
as episodic memory and language skills (14, 19-21). Similar to what has been 
demonstrated in normal ageing (22), performance in simple speeded tasks has often been 
found to account for a large proportion of depression-related variance in executive 
                                                 
1 The term ‘deficit’ is used to refer to reduced cognitive test performance in a patient group relative to a 
control group. It is acknowledged that a comprehensive clinical assessment would be required to indicate 
evidence of underlying brain dysfunction and/or functional impairment.  
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function as well as in overall cognition (14, 15, 20, 23). Such evidence has indicated that 
a primary deficit might be driving the broader cognitive deficit in late-life depression.  
The interrelationships amongst deficits in different cognitive domains have not received 
the same attention in the younger segment of the adult depressed population (18-65 
years). Relative to older adults, younger depressed patients exhibit less severe cognitive 
deficits, particularly in the domains of processing speed and executive function (24). In a 
meta-analysis of depressed patients of all ages, Snyder (25) argued that deficits in 
processing speed tasks could not fully account for the executive deficits. However, this 
conclusion was predominantly based on numerically smaller effect sizes for measures of 
processing speed compared to executive measures. Thus, it remains unclear whether the 
cognitive deficit in younger adult depressed patients is the result of a primary cognitive 
deficit, similarly to late-life depression, or the result of several relatively independent 
deficits originating in different cognitive domains.  
It is also not known to what extent deficits in different cognitive domains are influenced 
by various clinical factors in depression (12). A mapping of such influences could 
provide important information about the likely origins of cognitive deficits in depression 
(26). For example, if the impact of the severity of the current depressive episode 
predominates, cognitive performance in depression is likely to be merely a marker of 
current state. Alternatively, if illness duration over the lifetime predominates, cognitive 
performance may act as a trait marker of enduring and cumulative effects of depression 
on brain function. While results relating to clinical factors have been mixed (12), 
measures of attention and executive function have been put forward as potential trait-like 
markers in depression (27).  
Aims of the study 
The present study sought to investigate the hypothesis that a primary deficit in attention 
underpins the deficits in other affected cognitive domains in MDD. Importantly, for the 
hypothesis to be supported, the attention composite had to account for deficits in other 
affected cognitive domains as well as not being fully accounted for by variability in 
another cognitive domain. In an exploratory effort, the present study also investigated the 
impact of episode severity and illness duration on performance in different cognitive 
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domains. Given the sole focus on symptomatic patients, without consideration of 
treatment response or remission, such analyses were necessarily correlational in nature. 
Methodology 
Participants 
Thirty patients with a confirmed diagnosis of MDD and currently in a major depressive 
episode, as assessed by the Mini International Neuropsychiatric Interview (MINI; (28)), 
were recruited via their consultant psychiatrists. All patients had a Hamilton depression 
(HAM-D) score of 16 or greater, as assessed by the GRID HAM-D (29). Patient 
exclusion criteria included the presence of any other DSM-IV Axis 1 disorder (other than 
anxiety disorder considered secondary to a primary diagnosis of depression), present or 
past electroconvulsive therapy (ECT), a change in psychiatric medication in the last four 
weeks, dependence or harmful use of alcohol or any other drug in the past 12 months and 
recent participation in another research study that included similar neurocognitive 
assessments. A brief illness history was taken from all patients, including age of onset, 
total illness duration and number of hospitalizations.  
Thirty-four healthy volunteers were recruited as a control group. Exclusion criteria for 
the healthy volunteers comprised any history of psychiatric illness, as assessed by the 
MINI, any major physical health problem, self-report of one or more first degree relatives 
with a history of psychiatric illness, dependence or harmful use of alcohol or any other 
drug in the past 12 months and recent participation in research studies that included 
similar neurocognitive assessments. Both healthy volunteers and patients had to be right 
handed, as assessed by the Edinburgh Handedness Inventory (30), and could not have any 
fMRI contraindications, such as a pacemaker or other metal implants. All participants 
completed the National Adult Reading Test (NART; (31)) as a measure of premorbid 
intelligence and the Beck Depression Inventory II (BDI; (32)) as a self-report measure of 
depressive symptoms.   
The study was approved by the local NHS ethics committee (NRES Committee North 
East - Newcastle & North Tyneside 1) and all participants gave written, informed 
consent. 
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Neurocognitive assessment 
The neurocognitive assessment was designed to assess the cognitive domains of attention, 
executive function, visuospatial and verbal memory. All tests were administered 
according to standard procedure to allow comparison of results with other studies using 
the same tests (33). Tests were grouped according to the cognitive domain most 
commonly attributed to the particular test. Ability in each cognitive domain was 
estimated based on a minimum of three tests to increase the probability that the findings 
were reflective of the commonality of several tests (e.g. executive function) as opposed to 
being specific to the methodology (e.g. motor requirements) or scope (e.g. cognitive load) 
of a particular test (34). The use of composite scores is an established method in 
cognitive research for minimizing measurement error by a principle of aggregation (35). 
The attention and executive composites were derived from subtests of the same tasks by a 
method of subtraction (the subtraction method is used to derive a purer measure of 
executive function by better separating it from attentional demands; see Statistical 
Analysis section). Below we describe in detail the measurements that constituted each 
cognitive domain and how they were derived. 
Executive Function 
Three tasks were used to assess executive function and attention: the digit span 
from the WAIS-R (36), the Stroop Neuropsychological Screening Test (37) and 
the Trail Making Test (38).  
The subtests were selected to capture three subcomponents of executive 
functioning: updating, inhibition and set-shifting (39). The reverse digit span from 
the WAIS-R (36), in which participants were required to remember and repeat a 
random series digits in reverse order, was used to assess the updating component. 
The number of digits in each string increased as the task progressed with two 
trials for each string length. Memory span was defined as the longest string length 
at which participants answered correctly on both trials. To separate the executive 
component from the attentional demand of simply maintaining a string of digits in 
working memory, forward digit span (see Attention) was subtracted from the 
reverse digit span. Consequently, the score carried forward to the executive 
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function composite only constituted the executive aspect of the task, i.e. the 
ability to reverse a string of digits. 
The Stroop Neuropsychological Screening Test (37) was used to assess the 
inhibition component of executive function. In the incongruent condition of this 
task, interference is created between word reading and color naming by presenting 
participants with color words printed in a different color than the word itself 
denotes (e.g. the word ‘green’ written in red ink). By asking participants to name 
the color of the ink, the habit of reading the word itself has to be inhibited. The 
task also included two control condition, one of which required participants to 
name the color of crosses as quickly as possible. Response times in this control 
condition were subtracted from response times in the incongruent condition. 
Consequently, the score carried forward to analysis reflected the ability to inhibit 
the habit to read the color word, separate from the ability to attend to and name 
colors.  
Finally, Trail Making Part B (38) was used to assess the set shifting component. 
Participants were required to connect a series of numbers and letters in ascending 
numerical and alphabetical order respectively, alternating between numbers and 
letters, as quickly as possible. Time taken to complete the task was measured. In 
order to distinguish the executive component of shifting between two sets from 
the attentional demands required to follow a single set, Trail Making Part A (see 
Attention) was subtracted from Trail Making Part B. Consequently, the score 
carried forward to the executive function composite only constituted the ability to 
shift between two set orders, separate from the ability to follow a single set. 
Attention  
Four tests were used to assess attention. In Trail Making Part A task (38), 
participants were required to connect a series of numbers in ascending order as 
quickly as possible. The two control measures in the Stroop Neuropsychological 
Screening Test were also included in the attention composite, where color naming 
and reading speed required participants to name the color of crosses and read 
color words printed in black ink as quickly as possible, respectively (37). All 
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three tasks are expected to capture attentional abilities whilst not placing 
significant demands on executive function.  
The final task that contributed to the attention composite was the forward digit 
span from the WAIS-R, in which participants were required to repeat a random 
series of aurally presented digits (36). Whilst the task required attention to 
maintain the digit string in working memory, it did not involve any executive 
manipulation of the material. Memory span was defined in the same way as 
reverse digit span.  
Visuospatial Memory 
The visuospatial memory composite was derived from three tests: the Visual 
Patterns Test (VPT; (40)), the object-location memory task (OLM, (41)) and the 
Newcastle Visuospatial Working Memory task (NSWM, (42)). 
The VPT assessed short-term memory for visual patterns. Participants were 
shown visual matrix patterns for 3-s after which they were required to reproduce 
each pattern on an empty matrix after a short delay. The matrix patterns 
progressively increased in size with three trials for each size and difficulty level. 
The final score on the task constituted the last level at which all three trials were 
correct. 
The OLM task was developed to distinguish between three distinct processing 
mechanisms relevant to visuospatial memory: object processing, visuospatial 
location processing and object-to-location binding (41). In this task, participants 
were presented with a grid containing 10 objects for 30 seconds on a computer 
monitor. Subsequently, the objects disappeared and reappeared in a random order 
on a row above the square frame. In the position-only condition, all objects were 
the same and at recall the objects had to be relocated to their exact positions. In 
the object-to-location binding condition, all objects were different and at recall 
objects were relocated to their previous positions, which were indicated by black 
markers. In the combined condition, the two processes were combined and 
participants were asked to relocate ten different objects without marked positions. 
Performance in the position-only and combined conditions was measured in terms 
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of displacement error. Performance in the object-location binding condition was 
measured by the number of objects that were correctly placed on their respective 
marker. Two control conditions were also administered but were not used in the 
analyses.  
In the NSWM participants are required to search visuospatial locations (cups) for 
a hidden ball. The essential rule of the task was that once a ball had been found in 
a particular location, it would not appear there again. There was always the same 
number of balls to be found as there were locations, starting with 4 and 
progressing to 12. Two types of errors are recorded in the task: between-search 
errors, which referred to returning to a location in which a ball had already been 
found, and within-search errors, which constituted returning to a location which 
had already been found to be empty in the within the same search sequence. Only 
between-search errors were carried forward to analysis.  
Verbal Memory 
The Rey Auditory Verbal Learning Test (RAVLT; (43)) was used to assess verbal 
learning and immediate and delayed verbal memory. Participants were required to 
repeat a list of 15 aurally presented words immediately after presentation (A1). 
This procedure was repeated for the same list another four times (A2-A5). 
Subsequently, participants were presented with a second distractor list, which also 
had to be repeated immediately after presentation (B), after which they were 
required to recall the first list again (A6, immediate recall). After an approximate 
delay of 20 minutes, participants were asked to recall the initial list from memory 
without another presentation (A7, delayed recall). The subsequent recognition 
test, where participants were presented with a list with words from the first and 
second lists and new words and had to determine the source of the words, was not 
used for analyses. The verbal memory composite was derived from the total 
number of recalled words (A1 to A5, verbal learning) and from the immediate 
recall (A6) and delayed recall (A7). However, since the standard  delayed recall 
index at trial A6 and A7 is critically dependent on the number of words initially 
encoded (i.e., is confounded by words learned at trial A5), the percentage of 
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words retained from trial A5 at A6/A7 were used to provide a better index of 
retention per se (A6/A5*100; A7/A5*100).  
Statistical analysis 
Pearson’s correlational coefficients were used to evaluate the validity of the subtraction 
method for the tests of executive function and attention. Specifically, a weaker 
correlation between the attentional subtest (x) and the derived measure of executive 
function (y-x) compared to that between the attentional subtest (x) and the executive 
subtest (y) would provide support for an improved separation of attentional and executive 
capabilities through the subtraction method2. Pearson’s correlational coefficients were 
also used to investigate the relationships between the cognitive composites.  
Composite clustering was performed according to the cognitive domains most commonly 
attributed to the particular test. The composites were created by calculating an average of 
the relevant z-scores for each measure. Supplement (s1) presents the measurements that 
constituted the composites of executive function, attention, visuospatial memory and 
verbal memory. When Shapiro-Wilks test showed that the variables did not meet the 
assumptions of normality, log or square root transformations were applied. Only when 
the transformations resulted in an improvement of the normality of the variable was the 
transformed variable used. Z scores rather than raw scores were used for calculations of 
the composites, so that scoring schemes across tasks were standardized. These were 
derived from the raw scores with the formula (Xindividual- μcontrol / σcontrols). The former part 
of this equation was reversed for tasks in which a high score indicated poorer 
performance.  
A multivariate analysis of covariance (MANCOVA) was conducted to investigate group 
differences in overall cognitive ability. All cognitive composites were included as 
dependent variables, group (patient vs. controls) represented the independent variable and 
age, gender and premorbid IQ were entered as covariates. Subsequently, multiple 
                                                 
2 For example, the Trail Making Test has Parts A and B. Part B is generally considered a measure of 
executive function (shifting). However, the same motor/attentional demands required to complete part A 
are similarly involved in the performance of Part B. Therefore there is typically a moderate-to-strong 
correlation between Parts A and B. If instead the ‘difference’ is used (i.e. time to complete Part B minus 
Part A), it leads to a greater dissociation between the motor/attentional component and the ‘purer’ shift 
component.  
Attention and executive function in MDD 
11 
 
regression models were used to test the ability of one composites in accounting for 
between-group variance in another. To this end, a hierarchical method was used by which 
the first composite represented the dependent variable and the independent variables were 
added sequentially in an enter-model, starting with the all the demographic variables 
(age, gender, premorbid IQ), then the alternate composite and finally group membership 
(patient vs. control). Similar multiple regression models, restricted to the patient group, 
were tested to explore the effect of illness characteristics on the cognitive composites. 
All reported p values are two-tailed and no corrections have been made for multiple 
comparisons.  
Results 
Demographic and clinical characteristics 
Demographic and clinical characteristics of the depressed group and the control group are 
presented in Table 1. There were no statistically significant differences between the 
depressed group and the control group regarding age, gender and premorbid IQ. As a 
group, the depressed patients were experiencing a moderately severe depressive episode, 
had experienced several years of the illness and were generally taking antidepressant 
medication. 
{Inset Table 1 about here} 
Neurocognitive performance 
Two control subjects did not have complete data for the OLM and five patients did not 
have complete data for the RAVLT.  
Correlational analyses provided overall support for the validity of the subtraction method. 
For the Stroop Neuropsychological Screening Test, the derived executive measure 
(incongruent–colour naming) was unrelated to the attentional subtest (colour naming), 
r=0.032, p=0.804, which contrasts with the moderate correlation between the executive 
subtest (incongruent) and the attentional subtest (colour naming), r=0.517, p<0.001. For 
the Trail Making Test, the derived executive measure (Trails B–Trails A) was unrelated 
to the attentional subtest (Trails A), r=0.192, p=0.129, which contrasts with the strong 
correlation between the executive subtest (Trails B) and the attentional subtest (Trails A), 
Attention and executive function in MDD 
12 
 
r=0.621, p<0.001. For the digit span test from the WAIS-R, however, the correlation was 
comparable for the derived executive measure (reverse span–forward span) and the 
attentional subtest (forward span), r=0.472, p<0.001, and the executive subtest (reverse 
span) and the attentional subtest (forward span), 0.517, p<0.001.Table 2 presents the 
correlations amongst the cognitive composites and with the demographic variables in the 
sample as a whole. Attention was found to correlate significantly and positively with all 
other cognitive composites with a particularly strong correlation with executive function. 
There were also several significant correlations with age, gender and premorbid IQ, 
providing support for the need to use demographic variables as covariates in further 
analyses.  
{Inset Table 2 about here} 
 
A MANCOVA was conducted to investigate group differences in cognitive performance 
across the composites of attention, executive function, visuospatial memory and verbal 
memory, whilst controlling for age, gender and premorbid IQ. There was a significant 
main effect of group, evidencing a broad cognitive deficit in the depressed group (F(4, 49) 
= 3.37, p=0.016, η2p=0.216). When analyzing the composites separately, only attention 
(p=0.001) and executive function (p=0.009) reached significance, with depressed patients 
performing below the level of controls in both domains (Table 3). 
 
{Inset Table 3 about here} 
 
Considering the significant composites identified in the MANCOVA, attention and 
executive function, the next set of analyses assessed the ability of one of the composites 
in accounting for between-group variance in the other. Two multiple regression models 
were therefore tested, the first with attention as the dependent variable and the second 
with executive function as the dependent variable (Table 4). In Model 1, after accounting 
for demographic variables and executive function, group membership still accounted for 
a significant portion of the additional variance in attention (p=0.014). In contrast, in 
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Model 2, after accounting for demographic variables and attention, group membership 
did not account for any additional variance in executive function (p=0.196). 
Considering the potentially limited validity of the subtraction method for the digit span 
test from the WAIS-R, the regression models were repeated with composites that did not 
include the digit span test (s2). The outcome of the analyses remained the same for both 
models, as demonstrated in the supplement (s3).  
{Inset Table 4 about here} 
Another set of multiple regression analyses were conducted to investigate the effect of 
illness duration and illness severity on performance in the four cognitive domains (Table 
5). These analyses were restricted to the patient group (not being relevant to the control 
group). Illness duration was significant in the model implicating attention as the 
dependent variable, with a longer illness duration being associated with worse 
performance (p=0.005). Illness severity was not a significant variable in any of the four 
models.  
{Inset Table 5 about here} 
Discussion 
The present study found evidence for cognitive deficits in the domains of attention and 
executive function in a currently depressed sample relative to a matched control group. 
This is consistent with previous investigations demonstrating a multifaceted cognitive 
profile in depression, with particular resemblance to the pattern of deficits previously 
demonstrated in late-life depression (12, 18). Consequently, the hypothesized primary 
deficit in attention was assessed by evaluating its interrelationship with the deficit in 
executive function. In support of the hypothesis that a primary deficit in attention 
underpins deficits in executive function, group membership explained no additional 
variance in executive function once attention had been accounted for. In contrast, group 
membership continued to explain a significant portion of the variance in attention, even 
when executive function had been accounted for in the model.  
The results of the present study suggest that the cognitive deficits in depression may be 
secondary to a primary deficit in attention. This would be in line with the notion that the 
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cognitive profile in depression can be explained by deficits in more circumscribed, core 
processes (14). Given the speeded measures contributing to the attention composite in the 
present study, the results can also be considered consistent with previous findings in late-
life depression demonstrating that a deficit in information processing could account for 
deficits in other affected domains (15). Attention was also the only composite that 
demonstrated a relationship with a clinical variable, namely illness duration. With no 
significant relationships with symptom severity, this suggests that the attentional deficit is 
more likely to be the result of the accumulating burden of illness than of the severity of 
the current episode. In the context of previous demonstrations of moderate attentional and 
executive deficits even in remission (1), this finding appears to support the proposal that 
such deficits represent trait-like effects in depression (27). However, since all patients in 
the present study were symptomatic at the time of testing, future investigations will be 
necessary to reach a more definite conclusion in regards to whether the attentional deficit 
in depression is a state or a trait effect, or a combination of both.   
If a primary attentional deficit is indeed underlying the broader cognitive deficit seen in 
depression, it will be of great importance to identify its neurobiological underpinnings. 
Whilst such neurobiological causes are likely to originate from multiple sources with 
complex interactions, a potential candidate is white matter lesions and reduced white 
matter integrity. White matter has been identified as an important contributor to age-
related decline in processing speed and executive function, which both rely heavily on 
attentional resources (44). White matter abnormalities have also been reported in 
affective disorders (45-48) and have been found to particularly severe in individuals with 
a greater burden of depression (49). It is therefore conceivable that white matter 
abnormalities may represent one important contributor to the attentional deficit 
demonstrated in the present study (50, 51).  
It should be noted the executive and attention composites were derived from the same 
tasks, which comes with the risk of inflating the relationship between these particular 
composites. Importantly, however, this overlap in task procedure also allowed for the 
careful experimental separation between attention and executive function, which 
represents a strength of the present study. Directly related to this separation, the validity 
of the ‘subtraction method’ was statistically supported for two out of the three tests used 
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and the analysis of the interrelationship between the domains remained unchanged when 
the analysis included only those tests with supported validity. Also, despite the close 
relationship between attention and executive function, the results of the present study 
nevertheless demonstrate that the two composites differed in the extent to which they 
could account for between-group variability in the alternate domain. Another advantage 
of the assessment of executive function was that the selection of subtests was based on an 
established framework of executive function, where each subtest aimed to capture each of 
the distinct constructs (shifting, inhibition, updating; (52)).  
An important limitation of any study using composite scores is how tests are selected for 
the relevant composites. Given the small sample of the present study, a data driven 
approach for composite construction was not possible (e.g. principal component 
analysis). The findings therefore necessarily rest on the assumption that the included 
measures tap the intended cognitive domains. Another limitation is that complete data 
was not available for all participants for all tests, which reduced the statistical power for 
some of the analyses. Limited statistical power also hindered a correction for multiple 
comparisons, such as the Bonferroni correction, which represents an additional limitation 
of the study. It is also worth mentioning that since all tests and subtests were 
administered in a standardized manner and in the same order for all study participants, 
potential learning and order effects could not be evaluated. 
Finally, it is important to acknowledge the limitation of the used statistical methods in 
establishing a causal of for attention in driving the executive deficit. Such causal 
inferences could be made possible in future investigations by experimentally 
manipulating attentional and executive demands and carefully examining its effects on 
the overall cognitive profile in depression. Future investigations could also consider 
including additional/alternative measures of attention and executive function in order to 
examine the process specificity of the interrelationship between deficits in the two 
domains in depression.  
In conclusion, the present study provids evidence for a primary deficit in the attentional 
domain in a sample of symptomatic MDD patients of working age. The use of cognitive 
composites and the careful separation of cognitive domains, particularly of attention from 
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the highly related executive function domain, allowed an evaluation of the 
interrelationships amongst deficits in the two affected cognitive domains. Future 
investigations incorporating experimental manipulation of cognitive demand will be 
necessary to further delineate the role of attention in the cognitive profile in MDD and its 
neurobiological underpinnings.  
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Table 1            
Demographic and clinical characteristics                 
 Control (n=34)   Depressed (n=30)   
Variable M SD n Range   M SD n Range 
Test 
statistic p 
Demographic characteristics            
Age (years) 43 11  22-60  46.6 11.5  21-60 1.25 0.22 
Women   23     18  -0.63 0.53 
Men   11     12    
Premorbid IQ: NART 115 8.8  87-127   114 10.7  87-128 -0.42 0.67 
Mood ratings            
HAM-D (17) −   -  22.9 4.74  16-34   
BDI 1.9 3.3  0-14  35.1 11.2  14-53 16.51 < 0.001 
Clinical characteristics            
Age at illness onset (years)    -  28.3 13.3  13-56   
Duration of illness (years)    -  13.1 11.1  0.5-35   
Hospitalisation        4    
Medication            
Antidepressants (yes)        27    
Benzodiazapines (yes)        2    
Antipsychotics (yes)               5       
Abbreviations: National Adult Reading Test (NART), Hamilton Depression Rating Scale (HAM-D 17), Beck Depression Inventory (BDI)  
 
 
Table 2     
Pearson correlations between demographic variables and the cognitive compositesa  
Variable Attention b Executive Function c Visuospatial Memory d Verbal Memory e 
Attention - 0.622** 0.480** 0.470** 
Executive Function - - 0.382** 0.231 
Visuospatial Memory - - - 0.205 
Age -0.395** -0.356** -0.483** -0.132 
Gender † 0.418** 0.307* 0.143 0.374** 
Premorbid IQ 0.202 0.099 0.018 0.279* 
a Bold values indicate statistical significance; * p<0.05, ** p<0.01 
b Trail-Making A, Forward Digit Span, Stroop Reading Speed, Stroop Colour Naming  
c Trail-Making B, Reverse Digit Span, Stroop Interference Score   
d Newcastle Visuospatial Working Memory, Visual Patterns Test, Object Location Memory Task (position-only, object-location binding, combined 
conditions) 
e RAVLT (A1-A5, percentage retained at A6, percentage retained at A7) 
† Males coded as 1 and females as 2   
 
Table 3 
      
Results on MANCOVA tests comparing Z-score performance in the patient group and the control group 
in the four cognitive domains  a 
Domain Mean SD F(1,52) p η2p 
Attention -0.853 0.862 11.744 0.001 0.184 
Executive Function -0.525 0.649 7.446 0.009 0.125 
Visuospatial Memory -0.407 0.679 2.774 0.102 0.051 
Verbal Memory -0.557 1.067 1.949 0.169 0.036 
a Results are given for the 25 patients and 32 controls for whom data was available for all four composites 
 
 
 Table 4.  
 
Results of multiple regression analyses examining the ability of executive function to account for 
between-group variance in attention (Model 1) and vice versa (Model 2). The independent variables 
were added sequentially to the models. 
Dependent variable Independent variables R² R² change 
F for R² 
change p 
Model 1: Attention     
 Age, gender, premorbid IQ a 0.334 0.334 10.503 <0.001 
 + Executive function 0.505 0.161 19.161 <0.001 
 + Group: Patient vs. Control 0.554 0.049 6.382 0.014 
Model 2: Executive Function    
 Age, gender, premorbid IQ a 0.221 0.221 5.351 0.002 
 + Attention 0.404 0.193 19.161 <0.001 
  + Group: Patient vs. Control  0.422 0.017 1.709 0.196 
a 
Premorbid IQ as measures by the National Adult Reading Test  
 
Table 5       
Multiple regression analysis investigating the effect of illness duration (total number of years) and 
depression severity (HAM-D 17) on cognitive performance in the depressed group a.  
  β t p R2 F p 
Attention    0.445 3.689 0.013 
Age 0.007 0.041 0.968    
Gender 0.632 3.253 0.004    
Premorbid IQ 0.423 2.456 0.022    
Illness duration (years) -0.604 -3.086 0.005    
HAM-D (17) -0.337 -1.704 0.102    
Executive Function    0.382 2.848 0.038 
Age -0.287 -1.530 0.140    
Gender 0.177 0.863 0.397    
Premorbid IQ 0.066 0.362 0.721    
Illness duration (years) -0.372 -1.801 0.085    
HAM-D (17) 0.108 0.515 0.611    
Visuospatial Memory    0.407 3.161 0.026 
Age -0.430 -2.340 0.028    
Gender 0.438 2.184 0.039    
Premorbid IQ 0.180 1.010 0.323    
Illness duration (years) -0.285 -1.408 0.172    
HAM-D (17) -0.232 -1.136 0.268    
Verbal Memory    0.185 0.815 0.555 
Age 0.091 0.371 0.717    
Gender 0.281 1.098 0.287    
Premorbid IQ 0.303 1.259 0.224    
Illness duration (years) -0.029 -0.105 0.918    
HAM-D (17) 0.123 0.501 0.622       
a Bold values indicate statistical significance 
Table s1   
Measures constituting the four cognitive composites used for analyses. 
Domain Measures used for composite 
Executive Function Reverse Digit Span (span) - Forward Digit Span (span) 
 Stroop Incongruent (ms) - Stroop Colour Reading (ms; square root) 
 Trail Making B (ms) - Trail Making A (ms; square root) 
Attention Forward Digit Span (span) 
 Trail Making A (ms) 
 Stroop Reading Speed (ms; log) 
 Stroop Colour Naming (ms) 
Visuospatial Memory Visual Patterns Test (level) 
 OLM Position Only (displacement error; log) 
 OLM Object-Location Binding (error) 
 OLM Combined (displacement error) 
 NSWM 3D (between-search error) 
Verbal Memory RAVLT Verbal Learning (words recalled for A1-A5) 
 RAVLT Immediate Recall (% recalled at A6 from A5) 
  RAVLT Delayed Recall (% recalled at A7 from A5) 
Abbreviations: Object Location Memory (OLM), Newcastle Visuospatial Working Memory (NSWM), Rey 
Auditory Verbal Learning Test (RAVLT)  
 
Table s2   
Measures constituting the composites for Executive Function and Attention with the 
digit span test from the WAIS-R excluded. 
Domain Measures used for composite 
Executive Function Stroop Incongruent (ms) - Stroop Colour Reading (ms; square root) 
 
Trail Making B (ms) - Trail Making A (ms; square root) 
 
Attention Trail Making A (ms) 
 Stroop Reading Speed (ms; log) 
 Stroop Colour Naming (ms) 
 
 
Table s3.  
 
Results of multiple regression analyses examining the ability of executive function to account for 
between-group variance in attention (Model 1) and vice versa (Model 2), without inclusion of the 
subtests from the digit span test from the WAIS-R for the composites. The independent variables were 
added sequentially to the models. 
Dependent variable Independent variables R² R² change 
F for R² 
change p 
Model 1: Attention     
 Age, gender, premorbid IQ a 0.312 0.312 9.051 <0.001 
 + Executive function 0.436 0.124 12.967 0.001 
 + Group: Patient vs. Control 0.484 0.048 5.421 0.023 
Model 2: Executive Function    
 Age, gender, premorbid IQ a 0.203 0.203 5.093 0.003 
 + Attention 0.347 0.144 12.967 0.001 
  + Group: Patient vs. Control  0.596 0.009 0.777 0.382 
a 
Premorbid IQ as measures by the National Adult Reading Test  
